SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Volquardsen who wrote (943)3/6/1998 9:45:00 PM
From: John Zwiener  Read Replies (3) of 1115
 
I see you point Henry. That the directors put up little of their own
money. What I am getting at though is that the directors do have
options that total close to 1 million shares when converted (at around
2 1/4). In this sense at least, they do have something at stake. Most
of these options are vested or in the money (I think they can make up
the difference between the share price and option price to get the
shares). My point is that the increase in payment per meeting is
small change compared to the worth of their options.

I guess I will try to keep an open mind when the proxy arrives.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News